| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.173.10.6234 |
| P8608 | Fatcat ID | release_4o4x7ohdmje55hh6xui6jwqyym |
| P698 | PubMed publication ID | 15528361 |
| P5875 | ResearchGate publication ID | 8193002 |
| P2093 | author name string | Marie D Burdick | |
| Robert M Strieter | |||
| Steven L Kunkel | |||
| Christina A Addison | |||
| Jan Erik Ehlert | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6234-6240 | |
| P577 | publication date | 2004-11-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping | |
| P478 | volume | 173 |
| Q54238056 | A guide to chemokines and their receptors. |
| Q37046628 | An alternatively spliced variant of CXCR3 mediates the metastasis of CD133+ liver cancer cells induced by CXCL9 |
| Q30428793 | Angiostatic and chemotactic activities of the CXC chemokine CXCL4L1 (platelet factor-4 variant) are mediated by CXCR3. |
| Q43500476 | Angiostatic immune reaction in colorectal carcinoma: Impact on survival and perspectives for antiangiogenic therapy |
| Q35753903 | Association between preeclampsia and the CXC chemokine family (Review). |
| Q90481012 | C-X-C motif receptor 3A enhances proliferation and invasiveness of colorectal cancer cells, and is mediated by C-X-C motif ligand 10 |
| Q39501428 | CXC Chemokine Receptor 3 Alternative Splice Variants Selectively Activate Different Signaling Pathways |
| Q30432791 | CXC chemokines in cancer angiogenesis and metastases |
| Q45931583 | CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. |
| Q33552227 | CXCR3 activation by lentivirus infection suppresses neuronal autophagy: neuroprotective effects of antiretroviral therapy |
| Q44906072 | CXCR3 axis in patients with primary biliary cirrhosis: a possible novel mechanism of the effect of ursodeoxycholic acid |
| Q26826928 | CXCR3 in carcinoma progression |
| Q33816432 | CXCR3/ligands are significantly involved in the tumorigenesis of basal cell carcinomas |
| Q36985818 | Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression. |
| Q39098568 | Cancer cell-derived lymphotoxin mediates reciprocal tumour-stromal interactions in human ovarian cancer by inducing CXCL11 in fibroblasts |
| Q42256799 | Capacity of wild-type and chemokine-armed parvovirus H-1PV for inhibiting neo-angiogenesis |
| Q38994830 | Chemokine receptor CXCR3 deficiency exacerbates murine autoimmune cholangitis by promoting pathogenic CD8+ T cell activation |
| Q34520386 | Chemokine receptor CXCR3 promotes growth of glioma |
| Q34231598 | Chemokine receptor trio: CXCR3, CXCR4 and CXCR7 crosstalk via CXCL11 and CXCL12. |
| Q30426904 | Chemokines as mediators of angiogenesis. |
| Q30438032 | Chemokines as mediators of neovascularization |
| Q30427886 | Chemokines as mediators of tumor angiogenesis and neovascularization |
| Q86814803 | Chemokines in tumor progression and metastasis |
| Q61844875 | Chronic inflammatory lesions of the placenta are associated with an up-regulation of amniotic fluid CXCR3: A marker of allograft rejection |
| Q46959757 | Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis |
| Q49656814 | Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis? |
| Q90381865 | Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/CXCR3 Axis: A Review |
| Q98612891 | Evaluating the Role of CXCR3 in Pain Modulation: A Literature Review |
| Q54618538 | Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes. |
| Q102071906 | Expression and role of MIG/CXCR3 axis in mantle cell lymphoma |
| Q43939710 | Expression of a splice variant of CXCR3 in Crohn's disease patients; indication for a lymphocyte--epithelial cell interaction |
| Q37149868 | Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells |
| Q82527134 | Identification of a novel immunomodulatory gliadin peptide that causes interleukin-8 release in a chemokine receptor CXCR3-dependent manner only in patients with coeliac disease |
| Q91867240 | Immune and Smooth Muscle Cells Interactions in Atherosclerosis: How to Target a Breaking Bad Dialogue? |
| Q36129961 | Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosis |
| Q36279906 | Insect octopamine receptors: a new classification scheme based on studies of cloned Drosophila G-protein coupled receptors |
| Q33920086 | Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression. |
| Q37432097 | International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors |
| Q41628251 | Ligand activation induces different conformational changes in CXCR3 receptor isoforms as evidenced by plasmon waveguide resonance (PWR). |
| Q47880997 | Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines. |
| Q49524220 | Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands. |
| Q93090734 | Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumors |
| Q89848590 | Role of Chemokine (C-X-C Motif) Ligand 10 (CXCL10) in Renal Diseases |
| Q33816250 | Roles for aberrant CXCR3 signaling in basal cell carcinoma: a case for dual activity |
| Q34020909 | TNF-alpha-dependent regulation of CXCR3 expression modulates neuronal survival during West Nile virus encephalitis |
| Q38333255 | The CXC chemokine receptors of fish: Insights into CXCR evolution in the vertebrates. |
| Q57492052 | The Role of CXCR3 and Its Chemokine Ligands in Skin Disease and Cancer |
| Q37393013 | The chemokine receptors CXCR4 and CXCR3 in cancer |
| Q34263645 | The emerging role of CXC chemokines and their receptors in cancer |
| Q27010051 | The multifaceted functions of CXCL10 in cardiovascular disease |
| Q38023245 | The role of CXC chemokines and their receptors in the progression and treatment of tumors |
| Q30443091 | The role of CXC chemokines in pulmonary fibrosis |
Search more.